Over 1050 New Jersey Auctions End Today - Bid Now
Over 20 Total Lots Up For Auction at One Location - TX Cleansweep 06/25

Acibadem Maslak Hospital in Turkey begins treatments with MRIdian MR-image guided radiotherapy linac

Press releases may be edited for formatting or style | September 16, 2018 Rad Oncology Radiation Therapy
CLEVELAND, Sept. 13, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq :VRAY ) announced today that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's MRIdian® Linac, the world's first system to combine MRI guidance and linear accelerator radiation delivery. These treatments mark the first in Turkey using MRI-guided radiation therapy.

MRIdian MRI-guided radiotherapy represents the latest advance in the field of radiation oncology. The anatomical detail only available with MR soft tissue imaging enables on-table treatment plan adaptation to reshape radiation doses based on the anatomical changes which occur from one day of treatment to the next. Using a novel streaming video perspective, the technology also allows oncologists to visualize and automatically control beam delivery based on the real-time position of the tumor and surrounding organs.

"We are pleased to have commenced Turkey's first MRI-guided radiation therapy program and believe it offers cancer patients in our country a number of distinct benefits over traditional radiation therapy," said Enis Ozyar, M.D., Professor, Chairman of Acibadem University Department of Radiation Oncology. "MRIdian allows for clinical improvements in visualization and precision daily plan adaptation, and it provides us with the tools to deliver higher and potentially more effective radiation doses."

Acibadem Maslak Hospital is part of the Acibadem Healthcare Group, one of the leading institutions in Turkey in the field of private healthcare services. Comprised of 21 hospitals and 16 medical centers, Acibadem signed a joint partnership with IHH Healthcare in 2012 which enabled them to be a part of world's second largest healthcare chain. Turkey is currently one of the leading countries in health tourism due to the country's advanced diagnostic and treatment services offered.

In addition to treating a full spectrum of cancerous tumors, Acibadem Maslak Hospital intends to explore the benefit of local control, toxicity and survival with MRIdian Linac compared to standard radiotherapy technologies.


About ViewRay
ViewRay, Inc. (Nasdaq :VRAY ), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

Back to HCB News

You Must Be Logged In To Post A Comment